Read the Latest News

And the Committee heard from the American Association of Oral and Maxillofacial Surgeons

At the end of the NAM meeting, Dr. Gregory Ness, representing the American Association of Oral and Maxillofacial Surgeons (AAMOS) gave the following comments: “AAMOS welcomes the interest and support of the Academies, the NIH, NIDCR, FDA and The

What Allen Told the Committee

Allen Cowley addressed the second open-to-the-public meeting of the National Institute of Medicine's (NAM) Committee on Temporomandibular Disorders (TMD) held on March 28, 2019 in Washington, DC. No stranger to the world of TMD, Dr. Cowley is the hus

Some Thoughts on Depression

It is hardly surprising that the chronic pain and limitations in function that many long-time TMJ patients experience can be accompanied by a state of depression, a sense of exhaustion and hopelessness.

Upcoming NAM Public Webinars on TMD

The National Academy of Medicine's (NAM) Committee on Temporomandibular Disorders (TMD): From Research Discoveries to Clinical Treatment is hosting two public web conferences on Wednesday, June 19 and Wednesday, July 31.   Webinar 1: Pati

The NAM Committee Heard from Patients, Too

At the March 28, 2019 public meeting NAM committee members had a chance to hear from TMD patients who had submitted testimony for the record.

National Academy of Medicine Study on Temporomandibular Disorders

  • Jan 18, 2019

The first meeting of the National Academy of Medicine Committee on Temporomandibular Disorders (TMD): From Research Discoveries to Clinical Treatment will be held Tuesday, January 29, 2019 at the National Academy of Sciences building in Washington, D.C. 

An ad hoc committee will convene to address the current state of knowledge regarding TMD research, education and training, safety and efficacy of clinical treatments of TMD, and burden and costs associated with TMD. The committee will identify approaches to advance basic, translational, and clinical research in the field. The committee’s findings, conclusions, and recommendations will also inform development of policies related to evidence-based treatment and clinical management of TMD patients.

The afternoon session, scheduled from 1:30-5:00 p.m. Eastern Time, will offer the public an opportunity to understand the study's Statement of Task, and listen to presentations from key stakeholders.* The afternoon session will be available via webcast; however you will need to register. For those in the D.C. area, you are welcome to attend the meeting in person although registration is limited due to room capacity. The agenda and registration links can be found here.

*Please note there will be no public comment time at the January meeting, however, the committee will hold a patient/public stakeholder and public comment session at the committee’s March workshop (date TBD). 

TMJ Disorders


Login or Register to add Comment